These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 20463403)

  • 1. Role of mitochondrial amyloid-beta in Alzheimer's disease.
    Chen JX; Yan SS
    J Alzheimers Dis; 2010; 20 Suppl 2():S569-78. PubMed ID: 20463403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
    Chen X; Yan SD
    IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.
    Chen JX; Yan SD
    Expert Rev Neurother; 2007 Nov; 7(11):1517-25. PubMed ID: 17997700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
    Anandatheerthavarada HK; Devi L
    Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.
    Muirhead KE; Borger E; Aitken L; Conway SJ; Gunn-Moore FJ
    Biochem J; 2010 Feb; 426(3):255-70. PubMed ID: 20175748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.
    Swerdlow RH; Khan SM
    Med Hypotheses; 2004; 63(1):8-20. PubMed ID: 15193340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of [Gly14]-Humanin on beta-amyloid-induced PC12 cell death by preventing mitochondrial dysfunction.
    Jin H; Liu T; Wang WX; Xu JH; Yang PB; Lu HX; Sun QR; Hu HT
    Neurochem Int; 2010 Feb; 56(3):417-23. PubMed ID: 19941922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
    Crouch PJ; Harding SM; White AR; Camakaris J; Bush AI; Masters CL
    Int J Biochem Cell Biol; 2008; 40(2):181-98. PubMed ID: 17804276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.
    Caspersen C; Wang N; Yao J; Sosunov A; Chen X; Lustbader JW; Xu HW; Stern D; McKhann G; Yan SD
    FASEB J; 2005 Dec; 19(14):2040-1. PubMed ID: 16210396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
    Atamna H; Frey WH
    Mitochondrion; 2007 Sep; 7(5):297-310. PubMed ID: 17625988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors.
    Alberdi E; Sánchez-Gómez MV; Cavaliere F; Pérez-Samartín A; Zugaza JL; Trullas R; Domercq M; Matute C
    Cell Calcium; 2010 Mar; 47(3):264-72. PubMed ID: 20061018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.
    Cardoso SM; Santana I; Swerdlow RH; Oliveira CR
    J Neurochem; 2004 Jun; 89(6):1417-26. PubMed ID: 15189344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
    Wang X; Su B; Perry G; Smith MA; Zhu X
    Free Radic Biol Med; 2007 Dec; 43(12):1569-73. PubMed ID: 18037122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
    Rowan MJ; Klyubin I; Wang Q; Anwyl R
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial β-amyloid in Alzheimer's disease.
    Borger E; Aitken L; Muirhead KE; Allen ZE; Ainge JA; Conway SJ; Gunn-Moore FJ
    Biochem Soc Trans; 2011 Aug; 39(4):868-73. PubMed ID: 21787315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.
    Hauptmann S; Keil U; Scherping I; Bonert A; Eckert A; Müller WE
    Exp Gerontol; 2006 Jul; 41(7):668-73. PubMed ID: 16677790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction.
    Lim YA; Rhein V; Baysang G; Meier F; Poljak A; Raftery MJ; Guilhaus M; Ittner LM; Eckert A; Götz J
    Proteomics; 2010 Apr; 10(8):1621-33. PubMed ID: 20186753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.